(Q71218179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

Bubendorf L

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Sauter G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Moch H

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Schmid HP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Gasser TC

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Jordan P

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Mihatsch MJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 April 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

437-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8691323%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of prostatic cancer. Geographical distribution and time-trends

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

A report of the workshops on the current status of the histologic grading of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Prostatic carcinoma: problems in the interpretation of prostatic biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Neuroendocrine differentiation in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Neuro-endocrine cells--a new prognostic parameter in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Mitotic activity and prognosis in prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Proliferative activity in benign and neoplastic prostatic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Bombesin stimulates growth of human prostatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199604%29178%3A4%3C437%3A%3AAID-PATH484%3E3.0.CO%3B2-4

10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4

21 January 2018

Identifiers

DOI

0 references

1 reference